These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1067 related items for PubMed ID: 17107241

  • 1. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [Abstract] [Full Text] [Related]

  • 2. Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
    Takahashi H, Kamata M, Yoshida K, Ishigooka J, Higuchi H.
    J Clin Psychiatry; 2006 Oct; 67(10):1577-82. PubMed ID: 17107250
    [Abstract] [Full Text] [Related]

  • 3. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G, Early Psychosis Global Working Group.
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [Abstract] [Full Text] [Related]

  • 4. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL.
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 6. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
    Crespo-Facorro B, Pérez-Iglesias R, Mata I, Caseiro O, Martínez-Garcia O, Pardo G, Ramirez-Bonilla M, Pelayo-Terán JM, Vázquez-Barquero JL.
    J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
    Conley RR, Mahmoud R.
    Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    Alptekin K, Hafez J, Brook S, Akkaya C, Tzebelikos E, Ucok A, El Tallawy H, Danaci AE, Lowe W, Karayal ON.
    Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
    [Abstract] [Full Text] [Related]

  • 9. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B, Rodríguez-Sánchez JM, Pérez-Iglesias R, Mata I, Ayesa R, Ramirez-Bonilla M, Martínez-Garcia O, Vázquez-Barquero JL.
    J Clin Psychiatry; 2009 Apr 21; 70(5):717-29. PubMed ID: 19389335
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug 21; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 11. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA.
    Am J Psychiatry; 2004 Jun 21; 161(6):985-95. PubMed ID: 15169686
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I, IC-SOHO Study Group.
    J Clin Psychiatry; 2004 Mar 21; 65(3):312-21. PubMed ID: 15096069
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison.
    Crespo-Facorro B, Pérez-Iglesias R, Mata I, Ramirez-Bonilla M, Martínez-Garcia O, Pardo-Garcia G, Caseiro O, Pelayo-Terán JM, Vázquez-Barquero JL.
    J Psychopharmacol; 2011 Jun 21; 25(6):744-54. PubMed ID: 21292922
    [Abstract] [Full Text] [Related]

  • 14. Risperidone in treatment-refractory schizophrenia.
    Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC.
    Am J Psychiatry; 1999 Sep 21; 156(9):1374-9. PubMed ID: 10484947
    [Abstract] [Full Text] [Related]

  • 15. Belgian Schizophrenia Outcome Survey - results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol.
    Peuskens J, Gillain B, De Graeve D, Van Vleymen B, Albert A.
    Eur Psychiatry; 2009 Apr 21; 24(3):154-63. PubMed ID: 19118983
    [Abstract] [Full Text] [Related]

  • 16. Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis.
    Crespo-Facorro B, Pérez-Iglesias R, Mata I, Martínez-Garcia O, Ortiz V, Pelayo-Terán JM, Valdizan E, Vazquez-Barquero JL.
    Psychopharmacology (Berl); 2012 Jan 21; 219(1):225-33. PubMed ID: 21735072
    [Abstract] [Full Text] [Related]

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 21; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N, Foster RH, Olney R, Plosker GL.
    Drugs; 2001 Dec 21; 61(1):111-61. PubMed ID: 11217867
    [Abstract] [Full Text] [Related]

  • 19. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.
    Am J Psychiatry; 2005 Oct 21; 162(10):1888-95. PubMed ID: 16199835
    [Abstract] [Full Text] [Related]

  • 20. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ, Roychowdhury SM, Milton DR, Hill AL.
    J Clin Psychiatry; 2001 Oct 21; 62 Suppl 2():17-21. PubMed ID: 11232746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.